Status: December 18, 2020 3:23 p.m.
The Braunschweig company Corat Therapeutics has developed a drug against corona. It was very successful in animal experiments. Studies on sick people are now following.
So far, the researchers have only tested the antibodies on hamsters – but very successfully, according to the company. Accordingly, hamsters infected with the coronavirus and treated with COR-101 have recovered within two days. Hamsters who did not receive the drug reportedly took a week to reach the same level of health.
Drug prevents infection from progressing
“We are particularly pleased that COR-101 has drastically reduced the amount of Sars-CoV-2 in the lungs,” said the managing director Andreas Herrmann. The tests had shown that the drug efficiently neutralized the virus in the living organism and prevented the disease from progressing further. Another advantage of the agent is that it does not trigger the excessive immune response feared in the event of a corona infection. In addition, it is more resistant to mutations on the virus surface than other antibodies.
Study with corona patients from January
Currently the company is working hard on one Start of the first clinical studies in January. Unlike any previous vaccine study, these studies would Performed on infected patients from the start, Corat Therapeutics said. The company also assumes that an effect of the drug can be demonstrated much faster than in vaccine studies.
Further information
–
–
